相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mutant V600E BRAF increases hypoxia inducible factor-1α expression in melanoma
Suresh M. Kumar et al.
CANCER RESEARCH (2007)
Targeted inactivation of Fh1 causes proliferative renal cyst development and activation of the hypoxia pathway
Patrick J. Pollard et al.
CANCER CELL (2007)
Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma
S. Gad et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics
W. Marston Linehan et al.
CLINICAL CANCER RESEARCH (2007)
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells
Carla Boccaccio et al.
NATURE REVIEWS CANCER (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR and cancer: reason for dancing at the crossroads?
GV Thomas
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30H-kinase
T Nobukuni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase
MP Byfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor
S Hara et al.
ANNALS OF ONCOLOGY (2005)
The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses
EM Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma
HL Kim et al.
JOURNAL OF UROLOGY (2005)
Role of the ras-association domain family 1 tumor suppressor gene in human cancers
A Agathanggelou et al.
CANCER RESEARCH (2005)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
MB Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity
Y Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells
M Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
The hypoxia-induced paralogs scylla and charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila
JH Reiling et al.
GENES & DEVELOPMENT (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
MN Corradetti et al.
GENES & DEVELOPMENT (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development
YG Gangloff et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
TSC2: filling the GAP in the mTOR signaling pathway
Y Li et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Hypoxia inducible factor activates the transforming growth factor-α/epidermal growth factor receptor growth stimulatory pathway in VHL-/- renal cell carcinoma cells
L Gunaratnam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A nutrient sensor mechanism controls Drosophila growth
J Colombani et al.
CELL (2003)
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
JB Brugarolas et al.
CANCER CELL (2003)
Mutations in the Fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America
JR Toro et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Y Zhang et al.
NATURE CELL BIOLOGY (2003)
Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor
KM Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function
SS Schaim et al.
CURRENT BIOLOGY (2003)
The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif
H Nojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma
A Horiguchi et al.
JOURNAL OF UROLOGY (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth
JS Lee et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
XS Gao et al.
NATURE CELL BIOLOGY (2002)
Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway
C Treins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
ML Nickerson et al.
CANCER CELL (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
Loss of tumor suppressor protein PTEN during renal carcinogenesis
W Brenner et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
JK Maranchie et al.
CANCER CELL (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Exogenous amino acids regulate trophectoderm differentiation in the mouse blastocyst through an mTOR-dependent pathway
PM Martin et al.
DEVELOPMENTAL BIOLOGY (2001)
Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas
JH Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF
A Sodhi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
K Dreijerink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
HIF-1 and mechanisms of hypoxia sensing
GL Semenza
CURRENT OPINION IN CELL BIOLOGY (2001)
Regulation of cellular growth by the Drosophila target of rapamycin dTOR
HB Zhang et al.
GENES & DEVELOPMENT (2000)
Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin
S Oldham et al.
GENES & DEVELOPMENT (2000)
Synthesis of the translational apparatus is regulated at the translational level
O Meyuhas
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer
K Datta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
